Pharmaceutical companies have been announcing deals at breakneck speeds this year in what analysts say is an attempt to hedge risk and hike profits.
Amgen's first-quarter profit dropped 25% amid lower-than-expected sales for the biopharmaceutical firm.
Billionaire activist investor William Ackman said today that the way he accumulated his stake in Botox-maker Allergan was above the board and did not violate insider-trading laws.
Tuesday at 5p ET: Before you renovate … wait! We’ll tell you about a new trend that could make your investment pay off big time!
Tuesday at 7p ET: Obama has warned, threatened, and sanctioned, but Putin still won’t hear it! A former U.S. Ambassador shares insight on why he thinks the president’s Ukraine policy has failed!